title: MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease.
abstract: MicroRNAs are endogenous non-coding RNAs, approximately 22 nucleotides in length. They regulate gene expression and are important in a wide range of physiological and pathological processes. MicroRNA expression is tightly regulated during hematopoiesis and lymphoid cell differentiation and disruption of the entire microRNA network or selected microRNAs may lead to dysregulated immune responses. Abnormalities in microRNA expression related to inflammatory cytokines, Th-17 and regulatory T cells as well as B cells have been described in several autoimmune diseases. Sjogren's syndrome is characterized by features of systemic autoimmunity and chronic inflammation and dysfunction in exocrine organs. Its clinical characteristics along with the relatively easy access to the target tissue and its product makes Sjögren's syndrome appealing to study many aspects of microRNAs in a systemic autoimmune disease, such as their potential as diagnostic or prognostic biomarkers and their role in pathogenesis of autoimmunity, inflammation or organ dysfunction. Encouraging preliminary data from pilot studies in Sjogren's syndrome demonstrate the potential of microRNAs as putative diagnostic and prognostic biomarker candidates which should be tested in larger more definite studies. Combining the comparison of microRNA expression profiles between various clinical subsets of Sjögren's syndrome with bioinformatic modeling tools may predict formerly unsuspected pathways which may contribute to the disease process and lead to the generation of testable novel hypothesis of pathogenesis.
authors.affiliation: Sjögren's Syndrome Clinic, Molecular Physiology & Therapeutics Branch, National Institute of Dental and Craniofacial Research, Bethesda, MD, USA.
authors.forename: Ilias
authors.initials: I
authors.lastname: Alevizos
authors.forename: Gabor G
authors.initials: GG
authors.lastname: Illei
mesh_terms: D001172:Arthritis, Rheumatoid / Q000235:genetics; D001327:Autoimmune Diseases / Q000235:genetics* / Q000276:immunology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000235:genetics; D035683:MicroRNAs / Q000235:genetics / Q000502:physiology*; D009103:Multiple Sclerosis / Q000235:genetics; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology
chemical_list: D035683:MicroRNAs
references.citation: Mol Cell. 2007 May 25;26(4):523-37
references.pmid: 17531811
references.citation: Nature. 2008 Oct 23;455(7216):1124-8
references.pmid: 18806776
references.citation: Trends Cell Biol. 2008 May;18(5):199-209
references.pmid: 18396047
references.citation: Nat Immunol. 2009 Dec;10(12):1252-9
references.pmid: 19838199
references.citation: Arthritis Rheum. 2009 May;60(5):1294-304
references.pmid: 19404929
references.citation: Arthritis Res Ther. 2008;10(4):R101
references.pmid: 18759964
references.citation: Nat Cell Biol. 2007 Jun;9(6):654-9
references.pmid: 17486113
references.citation: Lancet. 2005 Jul 23-29;366(9482):321-31
references.pmid: 16039337
references.citation: PLoS One. 2007 Jul 11;2(7):e610
references.pmid: 17622355
references.citation: Nat Immunol. 2008 Aug;9(8):839-45
references.pmid: 18645592
references.citation: Cell Immunol. 2010;260(2):70-4
references.pmid: 19954774
references.citation: Nature. 2004 Nov 11;432(7014):235-40
references.pmid: 15531877
references.citation: Cell. 2006 Sep 22;126(6):1203-17
references.pmid: 16990141
references.citation: J Autoimmun. 2009 May-Jun;32(3-4):189-94
references.pmid: 19303254
references.citation: Curr Opin Rheumatol. 2009 Sep;21(5):465-70
references.pmid: 19568172
references.citation: Rheumatol Int. 2009 May;29(7):749-54
references.pmid: 18998140
references.citation: Nat Rev Immunol. 2008 Feb;8(2):120-30
references.pmid: 18204468
references.citation: Eur J Immunol. 2010 Mar;40(3):888-98
references.pmid: 20148420
references.citation: Nat Immunol. 2008 Apr;9(4):405-14
references.pmid: 18327259
references.citation: Arthritis Rheum. 2009 Apr;60(4):1065-75
references.pmid: 19333922
references.citation: Lupus. 2007;16(12):939-46
references.pmid: 18042587
references.citation: J Immunol. 2009 Apr 15;182(8):5088-97
references.pmid: 19342689
references.citation: Oral Dis. 2010 Jan;16(1):34-8
references.pmid: 19627513
references.citation: Curr Opin Mol Ther. 2009 Apr;11(2):189-99
references.pmid: 19330724
references.citation: Arthritis Rheum. 2008 May;58(5):1284-92
references.pmid: 18438844
references.citation: EMBO J. 2004 Oct 13;23(20):4051-60
references.pmid: 15372072
references.citation: Nat Clin Pract Rheumatol. 2008 Oct;4(10):534-41
references.pmid: 18728632
references.citation: J Autoimmun. 2009 May-Jun;32(3-4):246-53
references.pmid: 19345069
references.citation: J Clin Immunol. 2010 May;30(3):339-46
references.pmid: 20191314
references.citation: J Cell Sci. 2000 Oct;113 Pt 19:3365-74
references.pmid: 10984428
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8866-71
references.pmid: 18579786
references.citation: Cell. 2008 Apr 18;133(2):217-22
references.pmid: 18423194